LloydsPharmacy’s superintendent pharmacist Professor Steve Howard will retire at the end of this year, after 35 years with the company.   

Related Article: NHSE to ‘expand’ community pharmacy RSV vaccine offer

Professor Howard’s successor will be announced ‘in the next few weeks’, LloydsPharmacy said, but he will stay on as a part-time non-executive adviser to Lloyds’ parent company, McKesson UK, to oversee collective clinical standards and governance procedures.

Related Article: Afternoon inhaler use gives effective asthma control, study finds

Professor Howard joined LloydsPharmacy as a pharmacy manager, after starting his career as a hospital pharmacist. He is also a fellow of the Royal Pharmaceutical Society and serves as a visiting professor at the University of Huddersfield and the University of East Anglia.

Related Article: Pharmacists told to stop supplying blood pressure med with incorrect dose on pack

Toby Anderson, McKesson UK’s CEO, said: ‘Steve has made a great contribution throughout his career with our business and I would like to say a huge thank you to him for his dedication, service, leadership and professional guidance over the years and in particular during the recent considerable period of change.’